Cargando…

Association between serum angiotensin-converting enzyme 2 levels and postoperative myocardial infarction following coronary artery bypass grafting

Myocardial infarction (MI) is a predominant and severe complication in patients that undergo aortocoronary bypass surgery. Angiotensin-converting enzyme 2 (ACE2) activation is reportedly a protective mechanism in MI; therefore, in the present study, the association between serum ACE2 levels and post...

Descripción completa

Detalles Bibliográficos
Autores principales:	WANG, MIN, ZHANG, WEI, ZHOU, YU, ZHOU, XINMIN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043627/ https://www.ncbi.nlm.nih.gov/pubmed/24926374 http://dx.doi.org/10.3892/etm.2014.1640

Ejemplares similares

Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Mortality of Coronary Artery Bypass Grafting
por: Sharafi, Ahmad, et al.
Publicado: (2013)

Comparative Efficacy of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers after Coronary Artery Bypass Grafting
por: Kim, Jeayoun, et al.
Publicado: (2020)

Arg(972) Insulin receptor substrate-1 is associated with decreased serum angiotensin-converting enzyme 2 levels in acute myocardial infarction patients: in vivo and in vitro evidence
por: Liu, Wei, et al.
Publicado: (2013)

Relationship between Angiotensin Converting Enzyme, Apelin, and New-Onset Atrial Fibrillation after Off-Pump Coronary Artery Bypass Grafting
por: Xu, Shu, et al.
Publicado: (2017)

Screening Preoperative Peptide Biomarkers for Predicting Postoperative Myocardial Infarction after Coronary Artery Bypass Grafting
por: Jiang, Zhibin, et al.
Publicado: (2014)

Pregnancy after myocardial infarction and coronary artery bypass grafting – is it safe?
por: Janion-Sadowska, Agnieszka, et al.
Publicado: (2014)

Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Lim, Sungmin, et al.
Publicado: (2019)

Posttraumatic stress disorder after myocardial infarction and coronary artery bypass grafting
por: Singh, Amitoj, et al.
Publicado: (2017)

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Prothrombotic Processes and Myocardial Infarction Risk
por: Dézsi, Csaba András, et al.
Publicado: (2016)

Angiotensin-converting-enzyme inhibitor prevents skeletal muscle fibrosis in myocardial infarction mice
por: Kakutani, Naoya, et al.
Publicado: (2020)

Myocardial inflammation, injury and infarction during on-pump coronary artery bypass graft surgery
por: Alam, Shirjel R., et al.
Publicado: (2017)

Comparison of clinical outcomes of angiotensin receptor blockers with angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction
por: Chen, Chih-Wei, et al.
Publicado: (2023)

Serum FGF21 Levels Predict the MACE in Patients With Myocardial Infarction After Coronary Artery Bypass Graft Surgery
por: Xie, Wei, et al.
Publicado: (2022)

Serum Angiotensin Converting Enzyme in Pemphigus Vulgaris
por: Robati, Reza M, et al.
Publicado: (2014)

Timing of coronary artery bypass grafting after acute myocardial infarction: does it influence outcomes?
por: Thilak, Anton Prem, et al.
Publicado: (2021)

Optimal Timing of Coronary Artery Bypass Grafting in Haemodynamically Stable Patients after Myocardial Infarction
por: Bernard, Chloé, et al.
Publicado: (2023)

Comparative effect of angiotensin converting enzyme inhibitor versus angiotensin II type I receptor blocker in acute myocardial infarction with non-obstructive coronary arteries; from the Korea Acute Myocardial Infarction Registry—National Institute of Health
por: Ahn, Joon Ho, et al.
Publicado: (2020)

A meta-analysis of the efficacy of allopurinol in reducing the incidence of myocardial infarction following coronary artery bypass grafting
por: Singh, Tejas P., et al.
Publicado: (2018)

Postoperative Cognitive Dysfunction after Coronary Artery Bypass Grafting
por: Yuan, Shi-Min, et al.
Publicado: (2019)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Re-evaluating serum angiotensin-converting enzyme in sarcoidosis
por: Zheng, Shi-yue, et al.
Publicado: (2023)

Serum levels of angiotensin-converting enzyme 2 in children with Kawasaki disease
por: Gan, Yi, et al.
Publicado: (2022)

Impact of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers on clinical outcomes in hypertensive patients with acute myocardial infarction
por: Lee, Jae-Geun, et al.
Publicado: (2023)

Tenascin‐C aggravates ventricular dilatation and angiotensin‐converting enzyme activity after myocardial infarction in mice
por: Santer, David, et al.
Publicado: (2020)

In-hospital outcome of primary PCI for patients with acute myocardial infarction and prior coronary artery bypass grafting
por: Liu, Yu, et al.
Publicado: (2021)

Graft preservation confers myocardial protection during coronary artery bypass grafting
por: Szalkiewicz, Philipp, et al.
Publicado: (2022)

Coronary Subclavian Steal Syndrome Causing Acute Myocardial Infarction in a Patient Undergoing Coronary-Artery Bypass Grafting
por: Mandak, Jiri, et al.
Publicado: (2012)

Late Myocardial Infarction and Repeat Revascularization after Coronary Artery Bypass Grafting in Patients with Prior Percutaneous Coronary Intervention †
por: Biancari, Fausto, et al.
Publicado: (2022)

How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trial
por: Bonarjee, Vernon VS, et al.
Publicado: (2001)

Obstructive Sleep Apnea Increases the Risk of Perioperative Myocardial Infarction Following Off-Pump Coronary Artery Bypass Grafting
por: Fan, Kangjun, et al.
Publicado: (2021)

Myocardial Fluid Balance and Pathophysiology of Myocardial Edema in Coronary Artery Bypass Grafting
por: Zahara, Rita, et al.
Publicado: (2020)

The Efficacy of Angiotensin Receptor-Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Post Myocardial Infarction: A Meta-Analysis
por: Kotak, Sohny, et al.
Publicado: (2023)

Postoperative angioedema induced by angiotensin-converting enzyme inhibitor: case report
por: Bisinotto, Flora Margarida Barra, et al.
Publicado: (2019)

Propensity-matched analysis of the effect of preoperative intraaortic balloon pump in coronary artery bypass grafting after recent acute myocardial infarction on postoperative outcomes
por: Yu, Pey-Jen, et al.
Publicado: (2014)

Comparison of Outcomes Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Myocardial Infarction: A Meta-Analysis
por: Escobar, Johao, et al.
Publicado: (2023)

Irreversible myocardial cell injury and early postoperative function of the heart after coronary artery bypass grafting (CABG)
por: Karu, I, et al.
Publicado: (2004)

Diagnostic and Staging Value of Serum Angiotensin-Converting Enzyme in Sarcoidosis
por: Wang, Wenqiao, et al.
Publicado: (2022)

Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013)

Angiotensin Converting Enzyme Inhibition Reduces Cardiovascular Responses to Acute Stress in Myocardially Infarcted and Chronically Stressed Rats
por: Cudnoch-Jedrzejewska, A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oalp824o67m1jtl9a75e7tnsda